Influence of 17-Hydroxyprogesterone, Progesterone and Sex Steroids on Mineralocorticoid Receptor Transactivation in Congenital Adrenal Hyperplasia
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency leads to accumulation of steroid precursors and adrenal androgens. These steroids may have a biological effect on the steroid receptor with clinical consequences on diagnostics and treatment in CAH patients. Therefore, we analysed the effect of accumulated steroids [17-hydroxyprogesterone (17OHP), progesterone, androstenedione and testosterone] on aldosterone-mediated transactivation of the human mineralocorticoid receptor (hMR). METHODS: A transactivation assay using transiently transfected COS7 cells was employed. Cells were co-transfected with hMR-cDNA, MMTV-luciferase and renilla-luciferase expression vectors. Transfected cells were incubated with six different steroid concentrations in addition to aldosterone (10-10M). Luciferase and renilla activities were measured to quantify hMR transactivation. RESULTS: Linear regression analysis showed statistically significant linear inhibition of transactivation of the hMR by 10-10M aldosterone in the presence of increasing 17OHP [F(1,5) = 11.34, p = 0.019] and progesterone [F(1,5) = 11.08, p = 0.021] concentrations. In contrast, neither androstenedione nor testosterone affected hMR transactivation by aldosterone at a concentration of 10-10M. CONCLUSION: Our study shows for the first time that neither androstenedione nor testosterone has a biological effect on aldosterone-mediated transactivation of the hMR. 17OHP and progesterone have an anti-mineralocorticoid effect in vitro that may clinically lead to an increased requirement of mineralocorticoids in poorly controlled CAH patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“By contrast, 17OHP and progesterone inhibit aldosterone-mediated transactivation of the mineralocorticoid receptor in a dose-dependent fashion, explaining the strong antimineralocorticoid effect of 17OHP and progesterone in vitro (139,140).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [139]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Congenital Adrenal Hyperplasia
(1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,409
Congenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy
Geller, D. S., Farhi, A., Pinkerton, N., Fradley, M., Moritz, M., Spitzer, A., Meinke, G., Tsai, F. T. F., Sigler, P. B., & Lifton, R. P. (2000) · Science · doi:10.1126/science.289.5476.119 · Cited by 675
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients
Arlt, W., Willis, D. S., Wild, S. H., Krone, N., Doherty, E. J., Hahner, S., Han, T. S., Carroll, P. V., Conway, G. S., Rees, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0917 · Cited by 506
Self-citationThe Mineralocorticoid Receptor: Insights into its Molecular and (Patho)Physiological Biology
Viengchareun, S., Le Menuet, D., Martinerie, L., Munier, M., Tallec, L. P.-L., & Lombès, M. (2007) · Nuclear Receptor Signaling · doi:10.1621/nrs.05012 · Cited by 316
Rupprecht, R., Reul, J. M. H. M., van Steensel, B., Spengler, D., Söder, M., Berning, B., Holsboer, F., & Damm, K. (1993) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(93)90072-h · Cited by 298
Fejes-Tóth, G., Pearce, D., & Náray-Fejes-Tóth, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.2973 · Cited by 246
A Common Polymorphism in the Mineralocorticoid Receptor Modulates Stress Responsiveness
DeRijk, R. H., Wüst, S., Meijer, O. C., Zennaro, M.-C., Federenko, I. S., Hellhammer, D. H., Giacchetti, G., Vreugdenhil, E., Zitman, F. G., & de Kloet, E. R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0915 · Cited by 214
Cited by
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Self-citationCongenital Adrenal Hyperplasia
Witchel, S. F. (2017) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2017.04.001 · Cited by 184
Selective Progesterone Receptor Modulators—Mechanisms and Therapeutic Utility
Islam, M. S., Afrin, S., Jones, S. I., & Segars, J. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa012 · Cited by 143
“It shows very weak agonism with the glucocorticoid receptor (GR) (17) and antagonism with the mineralocorticoid receptor (MR) (18).”
BackgroundManagement challenges and therapeutic advances in congenital adrenal hyperplasia
Mallappa, A., & Merke, D. P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00655-w · Cited by 113
46,XX DSD: Developmental, Clinical and Genetic Aspects
Alkhzouz, C., Bucerzan, S., Miclaus, M., Mirea, A.-M., & Miclea, D. (2021) · Diagnostics · doi:10.3390/diagnostics11081379 · Cited by 58
“Excess hydroxyprogesterone, in the case of untreated 21-hydroxylase deficiency, has an antimineralocorticoid effect; this effect is more obvious in the case of severe and improperly treated patients [60].”
BackgroundMoss, M. E., Carvajal, B. V., & Jaffe, I. Z. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.06.009 · Cited by 51
Pijnenburg-Kleizen, K. J., Engels, M., Mooij, C. F., Griffin, A., Krone, N., Span, P. N., van Herwaarden, A. E., Sweep, F. C. G. J., & Claahsen-van der Grinten, H. L. (2015) · Endocrinology · doi:10.1210/en.2015-1087 · Cited by 35
“In addition, in a previous study of our group we have demonstrated that 17OHP and P can influence the transactivation of the human mineralocorticoid receptor: both have antimineralocorticoid effects in vitro (14).”
BackgroundSelf-citationMooij, C. F., Webb, E. A., Claahsen van der Grinten, H. L., & Krone, N. (2017) · Archives of Disease in Childhood · doi:10.1136/archdischild-2016-311910 · Cited by 31
Self-citationKocova, M., Anastasovska, V., & Falhammar, H. (2020) · Endocrine · doi:10.1007/s12020-020-02323-3 · Cited by 24
Travers, S. A. A., Bouvattier, C. M., Fagart, J., Martinerie, L., Viengchareun, S., Pussard, E., & Lombès, M. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00368.2019 · Cited by 17
Tschaidse, L., Reisch, N., Arlt, W., de la Perrière, A. B., Hirschberg, A. L., Juul, A., Mallappa, A., Merke, D. P., Newell-Price, J. D. C., Perry, C. G., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvac006 · Cited by 16
“18 The hMR antagonistic effect of progesterone and its metabolite 17OHP has also been demonstrated in patients with primary adrenal insufficiency.”
BackgroundInfluentialSelf-citationNeumann, U., van der Linde, A., Krone, R. E., Krone, N. P., Güven, A., Güran, T., Elsedfy, H. H., Poyrazoglu, S., Darendeliler, F., Bachega, T. A. S. S., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-1085 · Cited by 18
Self-citationSex Differences in Kidney Health and Disease
Harvey, B. J., & de la Rosa, D. Á. (2024) · The Nephron journals/Nephron journals · doi:10.1159/000541352 · Cited by 40
Rohayem, J., Zitzmann, M., Laurentino, S., Kliesch, S., Nieschlag, E., Holterhus, P., & Kulle, A. E. (2020) · Clinical Endocrinology · doi:10.1111/cen.14324 · Cited by 12
Mineralocorticoid replacement therapy in salt‐wasting congenital adrenal hyperplasia
Lang, K., Quinkler, M. O., & Kienitz, T. (2023) · Clinical Endocrinology · doi:10.1111/cen.14959 · Cited by 9
“17,46 In comparison, DOC reached 70% and cortisol only 10% of transactivation induced by aldosterone.”
InfluentialKolli, V., Frucci, E., da Cunha, I. W., Iben, J., Kim, S. A., Mallappa, A., Li, T., Faucz, F. R., Kebebew, E., Nilubol, N., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052543 · Cited by 4
Auer, M. K., Paizoni, L., Nowotny, H. F., Lottspeich, C., Tschaidse, L., Schmidt, H., Bidlingmaier, M., & Reisch, N. (2023) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2023.106271 · Cited by 3
Genetics and Pathophysiology of Congenital Adrenal Hyperplasia
Witchel, S. F. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-62470-9_5 · Cited by 4
Hamidi, O., Auchus, R. J., Correa, R. R., Levine, A. C., Wierman, M. E., Hartzell, A. L., Lin, V. H., & Bancos, I. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag147 · Cited by 4
Current and future perspectives on clinical management of classic 21-hydroxylase deficiency
Yogi, A., & Kashimada, K. (2023) · Endocrine Journal · doi:10.1507/endocrj.ej23-0075 · Cited by 2
Adriaansen, B. P. H., Utari, A., Chandra, E., Falhammar, H., Bonfig, W., Clemente, M., Lenherr‐Taube, N., Markosyan, R. L., de Miranda, M. C., Span, P. N., et al. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag298
A Rationale for Mineralocorticoid Supplementation in Classic Congenital Adrenal Hyperplasia
Speiser, P. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375531 · Cited by 1
Karaush‐Karmazin, N., Minaev, B. F., Minaeva, V. A., Panchenko, A. A., & Ågren, H. (2024) · Eurasian Journal of Chemistry · doi:10.31489/2959-0663/1-24-8 · Cited by 1
Yamamoto, T. (2019) · International Journal of Endocrinology and Metabolic Disorders · doi:10.16966/2380-548x.153 · Cited by 1
“Antagonistic activity of progesterone and 17-OHP against aldosterone receptor is shown in COS-7 cells, a cell line derived from African green monkey kidney, transfected with human mineralocorticoid receptor DNA [12].”
BackgroundA review on Congenital Adrenal Hyperplasia andits management
Toms, C., Fathima, B., Neethu, R., & Reji, A. (2024) · International Journal of Advanced Research in Biological Sciences (IJARBS) · doi:10.22192/ijarbs.2024.11.06.002 · Cited by 1
Stéroïdomique corticosurrénalienne par LC-MS/MS : applications en endocrinologie pédiatrique
Travers, S. A. A. (2020) · theses.fr (ABES) · doi:10.70675/84cf9c3bze93ez41dcza251z559f27f3c6a6
Nokoff, N., Fechner, P. Y., Kim, M. S., Marshall, I. H., Merke, D. P., Sarafoglou, K., Hartzell, A. L., Lin, V. H., & Thornton, P. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag192
Metadata
- Authors
- Mooij, C. F., Parajes, S., Pijnenburg-Kleizen, K. J., Arlt, W., Krone, N., & Claahsen-van der Grinten, H. L.
- Affiliations
- Radboud University Medical Center (NL)
- University of Birmingham (GB)
- Venue
- Hormone Research in Paediatrics
- Publisher
- S. Karger AG
- Published
- 2015
- Volume
- 83
- Issue
- 6
- Pages
- 414-421
- ISSN
- 1663-2818 (ISSN-L)
- 1663-2826
- OpenAlex
- W2019020433
- Cited by
- 27
- References
- 31
- Citations by year
- 2026: 3 · 2024: 4 · 2023: 4 · 2022: 2 · 2021: 2 · 2020: 4 · 2019: 3 · 2017: 2 · 2016: 1 · 2015: 2
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Hormone Research in Paediatrics (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- European Commission (255424)
- ZonMw
- Xunta de Galicia
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- congenital adrenal hyperplasia, 21-hydroxylase deficiency, mineralocorticoid receptor, 17-hydroxyprogesterone, progesterone, androstenedione, testosterone, sex steroids
- MeSH terms
- Adrenal Hyperplasia, Congenital, Aldosterone, Androstenedione, Animals, Chlorocebus aethiops, Humans, Progesterone, Testosterone, Transcriptional Activation, Receptors, Mineralocorticoid, 17-alpha-Hydroxyprogesterone, COS Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.